Flexible multivariate models for linking multi-scale connectome and genome data in Alzheimer's disease and related disorders

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3RF1AG063153-01A1S1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2019
    2024
  • Known Financial Commitments (USD)

    $143,254
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Vince D Calhoun
  • Research Location

    United States of America
  • Lead Research Institution

    Georgia State University
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Older adults (65 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Abstract COVID-19 is having a major impact around the world, however we are still learning about the mechanisms and manifestations of this illness. There is considerable evidence of neurologicalsymptoms that occur in COVID-19 patients. However the impact of this, and its relationship withage, on brain structure have not been studies at all thus far. We propose to use multivariate approaches to extract covarying brain patterns from individuals to study changes associated withCOVID-19 as well as potential interactions with age in older individuals. We will leverage the approaches being developed as part of the parent award, but customize them to incorporate spatial priors to address ischemic lesions. We will evaluate COVID-19 and age effects on these networks and compare them with networks extracted from normative data. We will share the methods via user friendly tools. Results are expected to provide insights into the neurological manifestations of COVID-19 including age specific effects.